Comparison of Ab positivity rate and NAT between healthy participants and RA patients also showed no significant difference, and the p-value for SARS-CoV-2 neutralizing antibodies and the NAT was 0.53 and 0.30, respectively (Figure 1). This evidence concerns the gene BRD2 and rheumatoid arthritis.